British Society of Echocardiography guideline for the transthoracic echocardiographic assessment of adult patients with obstructive hypertrophic cardiomyopathy receiving myosin-inhibitor therapy

Echo Res Pract. 2025 Jun 2;12(1):15. doi: 10.1186/s44156-025-00078-z.

¹ Liverpool Heart and Chest Hospital, Thomas Drive, Liverpool, L14 3PE, UK. Clare.Culshaw@lhch.nhs.uk.
² Royal United Hospitals Bath NHS Foundation Trust, Bath, Bath, UK.
³ University of Bath, Bath, UK.
⁴ Queen Elizabeth University Hospital, Glasgow, UK.
⁵ Manchester University NHS Foundation Trust, Manchester, UK.
⁶ Royal Brompton and Harefield Hospital, London, UK.
⁷ University Hospital Birmingham, Birmingham, UK.
⁸ Queen Elizabeth Hospital Birmingham, Birmingham, UK.
⁹ Royal Papworth Hospital, London, UK.
¹⁰ Guys and St Thomas Hospital, London, UK.
¹¹ Sports and Exercise Sciences, Liverpool John Moores University, Liverpool, UK.
¹² Liverpool Heart and Chest Hospital, Thomas Drive, Liverpool, L14 3PE, UK. Rob.Cooper@lhch.nhs.uk.
¹³ Sports and Exercise Sciences, Liverpool John Moores University, Liverpool, UK. Rob.Cooper@lhch.nhs.uk.

No abstract available

Keywords: Mavacamten; Myosin-inhibitor; Obstructive HCM; Surveillance Echocardiogram.

Publication types